FDAmepolizumab

Huqun Li1, Chongshu Wang2, Aiping Deng1

  • 1Department of Pharmacy, The Central Hospital of Wuhan, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.

Frontiers in pharmacology
|December 25, 2023
PubMed
概括

这项研究分析了关于梅波利祖马布不良事件 (AE) 的现实数据. 虽然常见的副作用被注意到,但长期儿科使用中咳和肺炎等意想不到的信号需要进一步调查.